(Q40100311)

English

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

scientific article

Statements

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit